Skip to main content
OpenTrials
Completed

NCT Number: NCT00302796

Antibiotic Treatment to Patients With Low Back Pain

A large proportion of patients with Low Back Pain (LBP) (80 %) are classified as "non-specific", due to the lack of a patho-anatomical diagnosis. This term is not satisfactory, since it implies uncertainty for both the patient and the clinician. Modic changes have recently been identified as a pain giving patho-anatomical diagnosis for a considerable percentage (20-30 %) of LBP patients. The causes of these Modic changes have not been determined conclusively but bacterial infection is among the plausible causes for those following a disc herniation.

Purpose The aim of this study is to assess the clinical effect of antibiotic treatment compared to placebo, in patients with LBP and Modic changes following a lumbar herniated disc.

Design A double blind prospective clinically controlled trial. Patients will be randomized by a blinded observer to either Group A: 1 antibiotic tablet 45 patients Group B: 1 placebo tablet 36 patients Group C: 2 antibiotic tablets 45 patients Group D: 2 placebo tablets 36 patients

The patients will take the drug three times a day for 100 days.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

The Back Research Center

Ringe, 5230, Denmark

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age between 18-65 years
  • Previous lumbar herniated disc confirmed by MRI
  • Time since lumbar disc herniation more than 6 months less than 2 years
  • LBP in the area of L1 to L5, with an added Low Back Pain Rating Scale of 6 or more
  • The present MRI shows Modic changes
  • Positive Springing test (SPT) at the level of Modic changes

Exclusion criteria

  • Allergy against antibiotics
  • The Beck Depression Inventory >7,
  • Pregnancy
  • Breast feeding
  • All Kidney diseases
  • Pending workers litigation or pension
  • Danish as second language
  • Fertile women who do not user safe anti conseption
  • Reduced liver functions
  • Reduced liver function due to previous treatment wiht amoxicillin/clavulanasid.

Treatment and study plan

Bioclavid

Drug

500 + 125 mg times 3 or 6

Placebo

Drug

Primary outcomes

  1. Low Back Pain Roland Morris Questionaire

    Time frame: One year follow-up

Sponsors and collaborators

Lead sponsor

The Back Research Center, Denmark

Other

Registry information

Official study title

Antibiotic Treatment to Patients With Low Back Pain Associated With Modic Changes Following Disc Herniation. A Randomized Clinical Controlled Trial

Important dates

Study start
2006
Primary completion
2009
Study completion
2009
First posted
Mar 15, 2006
Registry last updated
May 27, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.